Page last updated: 2024-08-23

lentinan and Recrudescence

lentinan has been researched along with Recrudescence in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, X; Cui, Z; Gu, S; Huang, X; Liu, X; Mei, H; Nie, G; Teng, W; Wang, K; Xu, J; Zhang, Y1
Hirose, N; Kawano, T; Matsusaki, K; Minamisono, Y; Miura, O; Morita, M; Nagasaki, S; Okamoto, F; Okazaki, Y; Toda, T; Yamada, T1
Oka, M; Yoshino, S1
Kobayashi, M; Kodera, Y; Matsui, T; Oba, K; Sakamoto, J1
Chihara, G; Jacques, PJ; Kanai, K; Kondo, E1

Reviews

1 review(s) available for lentinan and Recrudescence

ArticleYear
Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer.
    Anticancer research, 2009, Volume: 29, Issue:7

    Topics: Aged; Antineoplastic Agents; Female; Humans; Lentinan; Male; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Stomach Neoplasms

2009

Trials

1 trial(s) available for lentinan and Recrudescence

ArticleYear
[Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Immunotherapy; Lentinan; Neoplasm Staging; Oxonic Acid; Recurrence; Stomach Neoplasms; Survival Rate; Tegafur

2008

Other Studies

3 other study(ies) available for lentinan and Recrudescence

ArticleYear
Local delivery of biocompatible lentinan/chitosan composite for prolonged inhibition of postoperative breast cancer recurrence.
    International journal of biological macromolecules, 2022, Jan-01, Volume: 194

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Disease Models, Animal; Drug Delivery Systems; Female; Humans; Lentinan; Mice; Postoperative Care; Recurrence; Spectrum Analysis; Treatment Outcome; Xenograft Model Antitumor Assays

2022
[Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; Lentinan; Lung Neoplasms; Lymphatic Metastasis; Oxonic Acid; Recurrence; Stomach Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed

2008
Immunopotentiating effect of fungal glucans as revealed by frequency limitation of postchemotherapy relapse in experimental mouse tuberculosis.
    Japanese journal of medical science & biology, 1980, Volume: 33, Issue:6

    Topics: Adjuvants, Immunologic; Animals; Antitubercular Agents; Drug Therapy, Combination; Glucans; Lentinan; Male; Mice; Recurrence; Saccharomyces cerevisiae; Tuberculosis

1980